Advertisement

Topics

Johnson & Johnson Innovation meldet Beginn der Shanghai Lung Cancer Innovation QuickFire Challenge

10:41 EDT 14 Jun 2018 | FinanzNachrichten

Shanghai (ots/PRNewswire) - Johnson & Johnson Innovation, eine Division von Johnson & Johnson (China) Investment Ltd., meldete heuteden Beginn der Shanghai Lung Cancer Innovation QuickFire Challen...

Original Article: Johnson & Johnson Innovation meldet Beginn der Shanghai Lung Cancer Innovation QuickFire Challenge

NEXT ARTICLE

More From BioPortfolio on "Johnson & Johnson Innovation meldet Beginn der Shanghai Lung Cancer Innovation QuickFire Challenge"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...